LIFITEGRAST Recall D-0985-2022
Description: Xiidra (lifitegrast ophthalmic solution) 5% PROFESSIONAL SAMPLE, packaged in a) 5 single-use containers (0.2 mL each vial) (NDC 54092-606-07) and b) 4 pouches x 5 single-use containers (NDC 54092-606-04), Rx Only, Manufactured for: Shire US Inc., 300 Shire Way, Lexington, MA 02421.
LIFITEGRAST Recall D-0985-2022 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0985-2022 |
Event ID | 90176 |
Brand | XIIDRA |
Generic Name | LIFITEGRAST |
Manufacturer | LIFITEGRAST |
Original Package? | 1 |
Active Substance | LIFITEGRAST |
Drug Route | OPHTHALMIC |
Distribution | Nationwide within the United States |
Quantity | 279,179 vials |
Recall Reason | Failed Impurities/Degradation Specifications. |
Drug Classification | Class III |
Drug Code Info | 20220615 |
Product NDC | 54092-606 |
Product NUI | N0000192701 N0000192700 |
Pharma Class (EPC) | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] |
Recall Initiation Date | 20220510 |
Report Date | 20220615 |
Classification Date | 20220606 |
Address | 1 Health Plz East Hanover, NJ 07936-1016 United States |
Recalling Firm | Novartis Pharmaceuticals Corporation |
Initial Notification | Letter |
Unique Ingredient Identifier | 038E5L962W |
Drug Application Number | NDA208073 |
Structured Product Labeling (SPL ID) | 2648ebbb-5b5e-4497-adc2-db90088ba884 |
Structured Product Labeling (SPL Set ID) | ac09d19a-e321-4556-8a5c-66bd27cb6533 |
Similar To |